当前位置:首页 - 行情中心 - 科兴制药(688136) - 财务分析 - 现金流量表

科兴制药

(688136)

  

流通市值:54.22亿  总市值:54.22亿
流通股本:2.00亿   总股本:2.00亿

现金流量表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金864,229,786.56566,581,536.26284,336,267.681,228,222,997.33
收到的税费返还21,652.949,491.155,327.2212,673,043.41
收到其他与经营活动有关的现金31,040,785.6824,378,430.146,140,605.9125,461,801.31
经营活动现金流入的平衡项目0000
经营活动现金流入小计895,292,225.18590,969,457.55290,482,200.811,266,357,842.05
购买商品、接受劳务支付的现金138,844,276.92107,403,164.0654,505,989.18197,668,630.95
支付给职工以及为职工支付的现金172,341,672.82117,452,762.3954,880,374.66251,177,476.21
支付的各项税费50,118,861.0236,646,351.5911,137,681.7862,209,625.45
支付其他与经营活动有关的现金480,718,199.88363,496,337.71176,182,446.3842,437,454.05
经营活动现金流出的平衡项目0000
经营活动现金流出小计842,023,010.64624,998,615.75296,706,491.921,353,493,186.66
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额53,269,214.54-34,029,158.2-6,224,291.11-87,135,344.61
二、投资活动产生的现金流量:
收回投资收到的现金1,483,000,000942,000,000391,000,0001,984,049,461.23
取得投资收益收到的现金5,857,251.854,048,665.771,290,741.586,910,599.96
处置固定资产、无形资产和其他长期资产收回的现金净额31,2253,310--
收到的其他与投资活动有关的现金1,756,2001,676,2001,162,05020,956,616.35
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,490,644,676.85947,728,175.77393,452,791.582,011,916,677.54
购建固定资产、无形资产和其他长期资产支付的现金67,241,901.9150,905,761.937,750,594.55191,200,660.18
投资支付的现金1,645,000,0001,016,000,000579,000,0001,972,000,000
支付其他与投资活动有关的现金13,320,0502,200,000786,336.454,963,000
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,725,561,951.911,069,105,761.9617,536,9312,168,163,660.18
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-234,917,275.06-121,377,586.13-224,084,139.42-156,246,982.64
三、筹资活动产生的现金流量:
吸收投资收到的现金---12,727,600
取得借款收到的现金436,755,263.9311,354,263.9113,765,000420,625,132.95
筹资活动现金流入平衡项目0000
筹资活动现金流入小计436,755,263.9311,354,263.9113,765,000433,352,732.95
偿还债务支付的现金437,332,505.83218,535,034.4763,839,882.34354,016,158.32
分配股利、利润或偿付利息支付的现金33,494,795.6522,001,566.9910,957,252.445,413,092.24
支付其他与筹资活动有关的现金40,412,983.7937,984,332.7622,380,01317,676,089.6
筹资活动现金流出平衡项目0000
筹资活动现金流出小计511,240,285.27278,520,934.2297,177,147.74417,105,340.16
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-74,485,021.3732,833,329.6816,587,852.2616,247,392.79
四、汇率变动对现金及现金等价物的影响731,760.74971,110.16660,137.833,094,743.94
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-255,401,321.15-121,602,304.49-213,060,440.44-224,040,190.52
加:期初现金及现金等价物余额559,930,585.75559,930,585.75559,930,585.75783,970,776.27
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额304,529,264.6438,328,281.26346,870,145.31559,930,585.75
补充资料:
净利润-9,461,466.66--195,486,522.24
资产减值准备-2,187,250.09-2,561,695.3
固定资产和投资性房地产折旧-32,303,447.35-56,273,583.86
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-32,303,447.35-56,273,583.86
无形资产摊销-9,375,517.79-16,792,554.8
长期待摊费用摊销-2,864,894.54-11,008,432.16
处置固定资产、无形资产和其他长期资产的损失--100,857.6--281,292.19
固定资产报废损失-92,849.9-1,604,160.88
公允价值变动损失-13,940,667.35--238,629.61
财务费用-20,872,267.75-37,997,760.74
投资损失--4,084,588.18--6,934,038
递延所得税-16,780,923.83--70,311,594.75
其中:递延所得税资产减少-17,578,066.75--67,121,685.05
递延所得税负债增加--797,142.92--3,189,909.7
存货的减少-33,308,468.57--14,868,125.75
经营性应收项目的减少--181,337,648.93--70,167,363.72
经营性应付项目的增加--3,546,429.93-124,929,561.47
其他-3,107,919.48-7,719,495.73
现金的期末余额-438,328,281.26-559,930,585.75
减:现金的期初余额-559,930,585.75-783,970,776.27
公告日期2024-10-262024-08-202024-04-272024-04-27
审计意见(境内)标准无保留意见
TOP↑